PEAK6 Investments’s AstraZeneca AZN Stock Holding History

PEAK6 Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.4M	Buy	9,001 +1,251	+16%	+$202K	﹤0.01%	1708
2024 Q2	$1.21M	Buy	7,750 +4,248	+121%	+$639K	﹤0.01%	1690
2024 Q1	$474K	Sell	3,502 -877	-20%	-$116K	﹤0.01%	2485
2023 Q4	$590K	Buy	4,379 +881	+25%	+$115K	﹤0.01%	2499
2023 Q3	$474K	Buy	+3,498	New	+$478K	﹤0.01%	2435
2023 Q1	–	Sell	-10,177	Closed	-$1.38M	–	4251
2022 Q4	$1.38M	Sell	10,177 -33,485	-77%	-$4.2M	0.01%	1660
2022 Q3	$4.79M	Buy	+43,662	New	+$5.54M	0.02%	864
2021 Q2	–	Sell	-523	Closed	-$57.4K	–	5108
2021 Q1	$52K	Sell	523 -1,638	-76%	-$165K	﹤0.01%	4476
2020 Q4	$216K	Sell	2,161 -12,267	-85%	-$1.3M	﹤0.01%	3711
2020 Q3	$1.58M	Buy	14,428 +668	+5%	+$74.3K	﹤0.01%	1869
2020 Q2	$1.46M	Buy	13,760 +12,126	+742%	+$1.25M	0.01%	1758
2020 Q1	$146K	Buy	+1,634	New	+$154K	﹤0.01%	3083

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PEAK6 Investments's AZN Position: Q3 2024 in Review

PEAK6 Investments increased its AstraZeneca (AZN) stake by 16% in Q3 2024, buying an estimated $202K and bringing the position to 9,001 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

PEAK6 Investments first reported a position in AZN in Q1 2020 and has held it in 12 quarters since. The position peaked at $4.79M in Q3 2022. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

PEAK6 Investments held 9,001 shares of AstraZeneca worth $1.4M as of Q3 2024.
PEAK6 Investments bought 1,251 AstraZeneca shares in Q3 2024, an estimated $202K.
AstraZeneca made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1708 holding.
PEAK6 Investments first reported a position in AstraZeneca in Q1 2020 and has held it in 12 quarters since.
PEAK6 Investments's AstraZeneca position peaked at $4.79M in Q3 2022.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.